Case Report

Two Cases of Dedifferentiated Endometrioid Carcinoma: Case Presentation and Brief Review of the Literature

Table 1

Cases of dedifferentiated endometrial carcinoma (DEC).

AuthorYearNo. casesAgeStage (cases)Treatment (cases)Adjuvant therapy (cases) UC component, %Outcome (cases)

J. Han [7]2017454IATH+BSO+PLA+PALANot treated30NED (19 monhts)
77IIATH+BSO+PLANot treated20DOD (7 weeks)
52IIATH+BSO+PLA+PALARadiation (EBRT+ICR)60NED (39 months)
60IIISRH+BSOChemotherapy (CDDP+ADM+CPA) and Radiation (EBRT+ICR)90DOD (10 months)
R. Yokomizo [8]2017366IATH+BSO+PLA+PALA
ATH+BSO+OMX+
Chemotherapy
(CDDP+ADM)
45NED (24 months)
48IIIRight hemicolectomy+ Hartmann operationChemotherapy
(PTX+CBDCA)
90DOD (5 months)
48IVATH+BSO+OMX+PLA+PALARadiation (EBRT)60DOD (7 months
Z. Li [9]20161361 (median)I/II (1)NAChemotherapyNA
III/IV (12)NANADFI(>3 months) 10%
C. J. Stewart [10]20151768.5 (mean) (range: 49-86)I (7)NANANANA
II (1)
III/IV (9)
E. S. Wu [11]2013162IVT10-T12 laminectomyRadiation and hormonal therapy (TAM)NANA
R. Berretta [12]2013167IVATH+BSO+AdrenalectomyChemotherapy (PTX+CBDCA)NANA
Y. Shen [13]2012151IIATH+BSO+PLA Vaginal radiation and chemotherapy (CDDP+DTX+Taxane)20NED (11 months)
G. Giordano [14]2012283IATH+BSO+PLANAalmost allAWD (12 months)
61IIIATH+BSO+PLANA85DOD (3 months)
G. Vita [15]2011145IIIATH+BSOChemotherapy (CDDP+ anthracycline+taxane)40NA
E. G. Silva [1]20062551 (median) (range: 30-82)I (14)
ATH+BSO (24)Chemothrapy (18)
Radiation (4)
Not treated (3)
20-90DOD
(median 7 months)(15)
II (1)AWD (6)
III (6)NA (3)
IV (4)NED (104 months)(1)